Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted to $201M-$211M. Analysts downgrade, citing competitive challenges.
Shares of RingCentral, Inc. (NYSE:RNG) rose sharply in today’s pre-market trading after the company reported better-than-expected first-quarter financial…